Rare earths and critical minerals are expected to take a growing slice of Australia's resources pie in the years to come.

Despite its due late-stage stem cell trial failures, Cynata is passing the hat for just over $900,000 in an underwritten ...

The ASX slid 0.76% as miners and banks weighed, while defensives found support and MAAS Group plunged on growing doubts over ...

Tully looks at Ark Mines and the rare earth extraction rates proving its Sandy Mitchell monazite concentrate responds to ...

Australia has a rich history of mineral sands mining, with a new generation of ASX players now chasing the next supply wave.

The Big Four are hiking credit card costs and cutting rewards as RBA reforms squeeze fee income, but fresh perks offer some ...

Island’s shot at gaining US FDA approval for antiviral Galidesivir for Marburg virus under the Animal Rule presents lucrative opportunities ...

Moonlight (ASX:ML8) is building a gold and critical minerals portfolio across QLD and the NT, led by its flagship Clermont gold project.

UniSuper’s chief investment officer has no plans to invest in Firmus Technologies’ $44bn float, warning that loss-making AI companies will keep tapping investors for cash for years.

The ASX snapped a three-day winning streak as banks and miners weighed, while uranium stocks lit up after Google’s big ...

Amid a rash of disappointing late-stage clinical study results, drug developers are smashing out some decent mid-stage success.

Core Lithium's junior neighbour, which trades at a fraction of its market cap, could rerate according to an Aussie mining ...